Walking the talk in digital transformation of regulatory review.

Front Med (Lausanne)

Amgen (United States), Thousand Oaks, CA, United States.

Published: July 2023

Cloud-based regulatory platforms have the potential to substantially transform how regulatory submissions are developed, transmitted, and reviewed across the full life cycle of drug development. The benefits of cloud-based submission and review include accelerating critical therapies to patients in need globally and efficiency gains for both drug developers and regulators. The key challenge is turning the theoretical promise of cloud-based regulatory platforms into reality to further the application of technology in the regulatory processes. In this publication we outline regulatory policy journeys needed to effect the changes in the external environment that would allow for use of a cloud-based technology, discuss the prerequisites to successfully navigate the policy journeys, and elaborate on future possibilities when adoption of cloud-based regulatory technologies is achieved.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411640PMC
http://dx.doi.org/10.3389/fmed.2023.1233142DOI Listing

Publication Analysis

Top Keywords

cloud-based regulatory
12
regulatory platforms
8
policy journeys
8
regulatory
7
cloud-based
5
walking talk
4
talk digital
4
digital transformation
4
transformation regulatory
4
regulatory review
4

Similar Publications

Introduction: The convergence of healthcare with the Internet of Things (IoT) and Artificial Intelligence (AI) is reshaping medical practice with promising enhanced data-driven insights, automated decision-making, and remote patient monitoring. It has the transformative potential of these technologies to revolutionize diagnosis, treatment, and patient care.

Purpose: This study aims to explore the integration of IoT and AI in healthcare, outlining their applications, benefits, challenges, and potential risks.

View Article and Find Full Text PDF

TPD-seq: A high throughput RNA-seq method to derive transcriptomic points of departure from cell lines.

Toxicol In Vitro

December 2024

Faculty of Agricultural and Environmental Sciences, McGill University, Montreal, Canada. Electronic address:

There is growing scientific and regulatory interest in transcriptomic points of departure (tPOD) values from high-throughput in vitro experiments. To further help democratize tPOD research, here we outline 'TPD-seq' which links microplate-based exposure methods involving cell lines for human (Caco-2, Hep G2) and environmental (rainbow trout RTgill-W1) health, with a commercially available RNA-seq kit, with a cloud-based bioinformatics tool (ExpressAnalyst.ca).

View Article and Find Full Text PDF

Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was based on an investigational drug services model and a Food and Drug Administration-compliant database to manage blood product inventory and trial safety.

Methods: A core investigational team adapted a cloud-based platform to randomize patient assignments and track inventory distribution of control plasma and high-titer COVID-19 convalescent plasma of different blood groups from 29 donor collection centers directly to blood banks serving 26 transfusion sites.

View Article and Find Full Text PDF

Introduction: With technological advancements and the growing prevalence of smartphones, ophthalmology has opportunely harnessed medical technology for visual function assessment as a home monitoring tool for patients. Ophthalmology applications that offer these have likewise become more readily available in recent years, which may be used for early detection and monitoring of eye conditions. To date, no review has been done to evaluate and compare the utility of these apps.

View Article and Find Full Text PDF

Cloud Horizons: Strengthening Rural Healthcare Through Telemedicine's Digital Canopy.

Health Serv Insights

September 2024

Lead Software Engineer, IntraEdge Inc, Irving, TX, USA.

Introduction: Cloud-based telemedicine holds promise for improving healthcare accessibility and delivery, particularly in rural areas of developing countries like Tanzania. However, little is known about its determinants and benefits in such contexts. This study investigates the factors influencing the usage of telemedicine in Mvomero district, Morogoro region, Tanzania, focusing on both supply and demand sides.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!